Posts Tagged ischemic stroke

[ARTICLE] An Exploratory Study of Predictors of Response to Vagus Nerve Stimulation Paired with Upper-Limb Rehabilitation After Ischemic Stroke – Full Text


We have previously shown the safety and feasibility of vagus nerve stimulation (VNS) paired with upper-limb rehabilitation after ischemic stroke. In this exploratory study, we assessed whether clinical and brain MRI variables predict response to treatment. We used data from two completed randomised and blinded clinical trials (N = 35). All participants had moderate to severe upper-limb weakness and were randomised to 6-weeks intensive physiotherapy with or without VNS. Participants had 3 T brain MRI at baseline. The primary outcome was change in Fugl-Meyer Assessment, upper-extremity score (FMA-UE) from baseline to the first day after therapy completion. We used general linear regression to identify clinical and brain MRI predictors of change in FMA-UE. VNS-treated participants had greater improvement in FMA-UE at day-1 post therapy than controls (8.63 ± 5.02 versus 3.79 ± 5.04 points, t = 2.83, Cohen’s d = 0.96, P = 0.008). Higher cerebrospinal fluid volume was associated with less improvement in FMA-UE in the control but not VNS group. This was also true for white matter hyperintensity volume but not after removal of an outlying participant from the control group. Responders in the VNS group had more severe arm impairment at baseline than responders to control. A phase III trial is now underway to formally determine whether VNS improves outcomes and will explore whether these differ in people with more severe baseline upper-limb disability and cerebrovascular disease.


Vagus nerve stimulation (VNS) paired with upper-limb rehabilitation is a potential novel treatment for arm weakness after stroke. VNS triggers release of plasticity promoting neuromodulators, such as acetylcholine and norepinephrine, throughout the cortex1. Timing this with motor training drives task-specific plasticity in the motor cortex2 and VNS paired with rehabilitative training has been shown to improve recovery in different preclinical models of stroke, both in comparison to VNS alone and rehabilitation alone3,4. These improvements were associated with synaptic reorganization of cortical motor networks and recruitment of residual motor neurons controlling the impaired forelimb5. Two clinical studies comparing VNS paired with upper-limb rehabilitation with upper-limb rehabilitation alone have shown it to be acceptably safe and feasible and that it may improve arm weakness after ischemic stroke6,7.

Arm weakness is the most common symptom of stroke and approximately half of stroke survivors with arm weakness have prolonged disability, which is associated with reduced quality of life8,9. Restoration of arm function after stroke is a priority for many stroke survivors10. However, recovery of motor function after stroke varies, so identifying factors that help predict response is important to aid patient selection and identify those most likely to respond. This is particularly true where therapies are invasive (involving surgery) and/or time consuming; VNS requires implantation of a nerve stimulator which is costly and associated with risks of anaesthesia, a small risk of infection and small risk of vocal cord palsy. There are several clinical and brain imaging markers that predict cognitive and functional recovery after stroke including age, level of impairment, white matter hyperintensity (WMH) volume, stroke lesion volume, corticospinal tract damage and blood pressure level11,12,13.

In the present study, we combined clinical and brain magnetic resonance imaging (MRI) data from our two previous randomised trials of VNS paired with rehabilitation for the upper-limb after ischemic stroke6,7. We performed exploratory analyses to assess predictors of response to VNS paired with upper-limb rehabilitation. Our goal was to identify predictive factors for further study that may help with patient selection for this promising novel therapy. […]


Continue —->  An Exploratory Study of Predictors of Response to Vagus Nerve Stimulation Paired with Upper-Limb Rehabilitation After Ischemic Stroke | Scientific Reports


Illustration of brain MRI measures obtained. (A) Raw FLAIR image. (B) Segmentation of white matter hyperintensities (WMH; bright red) and ischaemic stroke infarct volumes (royal blue). (C) Estimate of the left (cyan) and right (pink) corticospinal tracts. (D) Interaction between stroke lesion (dull red) and corticospinal tract (light blue) in a 3D rendering. Images A and B come from the same patient, C and D are from separate patients and all are shown in neurological (“left is left”) convention.

, , , , , , ,

Leave a comment

[ARTICLE] Neurotechnology-aided interventions for upper limb motor rehabilitation in severe chronic stroke – Full Text


Upper limb motor deficits in severe stroke survivors often remain unresolved over extended time periods. Novel neurotechnologies have the potential to significantly support upper limb motor restoration in severely impaired stroke individuals. Here, we review recent controlled clinical studies and reviews focusing on the mechanisms of action and effectiveness of single and combined technology-aided interventions for upper limb motor rehabilitation after stroke, including robotics, muscular electrical stimulation, brain stimulation and brain computer/machine interfaces. We aim at identifying possible guidance for the optimal use of these new technologies to enhance upper limb motor recovery especially in severe chronic stroke patients. We found that the current literature does not provide enough evidence to support strict guidelines, because of the variability of the procedures for each intervention and of the heterogeneity of the stroke population. The present results confirm that neurotechnology-aided upper limb rehabilitation is promising for severe chronic stroke patients, but the combination of interventions often lacks understanding of single intervention mechanisms of action, which may not reflect the summation of single intervention’s effectiveness. Stroke rehabilitation is a long and complex process, and one single intervention administrated in a short time interval cannot have a large impact for motor recovery, especially in severely impaired patients. To design personalized interventions combining or proposing different interventions in sequence, it is necessary to have an excellent understanding of the mechanisms determining the effectiveness of a single treatment in this heterogeneous population of stroke patients. We encourage the identification of objective biomarkers for stroke recovery for patients’ stratification and to tailor treatments. Furthermore, the advantage of longitudinal personalized trial designs compared to classical double-blind placebo-controlled clinical trials as the basis for precise personalized stroke rehabilitation medicine is discussed. Finally, we also promote the necessary conceptual change from ‘one-suits-all’ treatments within in-patient clinical rehabilitation set-ups towards personalized home-based treatment strategies, by adopting novel technologies merging rehabilitation and motor assistance, including implantable ones.


Stroke constitutes a major public health problem affecting millions of people worldwide with considerable impacts on socio-economics and health-related costs. It is the second cause of death (Langhorne et al., 2011), and the third cause of disability-adjusted life-years worldwide (Feigin et al., 2014): ∼8.2 million people were affected by stroke in Europe in 2010, with a total cost of ∼€64 billion per year (Olesen et al., 2012). Due to ageing societies, these numbers might still rise, estimated to increase 1.5–2-fold from 2010 to 2030 (Feigin et al., 2014).

Improving upper limb functioning is a major therapeutic target in stroke rehabilitation (Pollock et al., 2014Veerbeek et al., 2017) to maximize patients’ functional recovery and reduce long-term disability (Nichols-Larsen et al., 2005Veerbeek et al., 2011Pollock et al., 2014). Motor impairment of the upper limb occurs in 73–88% first time stroke survivors and in 55–75% of chronic stroke patients (Lawrence et al., 2001). Constraint-induced movement therapy (CIMT), but also standard occupational practice, virtual reality and brain stimulation-based interventions for sensory and motor impairments show positive rehabilitative effects in mildly and moderately impaired stroke victims (Pollock et al., 2014Raffin and Hummel, 2018). However, stroke survivors with severe motor deficits are often excluded from these therapeutic approaches as their deficit does not allow easily rehabilitative motor training (e.g. CIMT), treatment effects are negligible and recovery unpredictable (Byblow et al., 2015Wuwei et al., 2015Buch et al., 2016Guggisberg et al., 2017).

Recent neurotechnology-supported interventions offer the opportunity to deliver high-intensity motor training to stroke victims with severe motor impairments (Sivan et al., 2011). Robotics, muscular electrical stimulation, brain stimulation, brain computer/machine interfaces (BCI/BMI) can support upper limb motor restoration including hand and arm movements and induce neuro-plastic changes within the motor network (Mrachacz-Kersting et al., 2016Biasiucci et al., 2018).

The main hurdle for an improvement of the status quo of stroke rehabilitation is the fragmentary knowledge about the physiological, psychological and social mechanisms, their interplay and how they impact on functional brain reorganization and stroke recovery. Positive stimulating and negatively blocking adaptive brain reorganization factors are insufficiently characterized except from some more or less trivial determinants, such as number and time of treatment sessions, pointing towards the more the better (Kwakkel et al., 1997). Even the long accepted model of detrimental interhemispheric inhibition of the overactive contralesional brain hemisphere on the ipsilesional hemisphere is based on an oversimplification and lack of differential knowledge and is thus called into question (Hummel et al., 2008Krakauer and Carmichael, 2017Morishita and Hummel, 2017).

Here, we take a pragmatic approach of comparing effectiveness data, keeping this lack of knowledge of mechanisms in mind and providing novel ideas towards precision medicine-based approaches to individually tailor treatments to the characteristics and needs of the individual patient with severe chronic stroke to maximize rehabilitative outcome.[…]

Continue —>   Neurotechnology-aided interventions for upper limb motor rehabilitation in severe chronic stroke | Brain | Oxford Academic

Conceptualization of longitudinal personalized rehabilitation-treatment designs for patients with severe chronic stroke. Ideally, each patient with severe chronic stroke with a stable motor recovery could be stratified based on objective biomarkers of stroke recovery in order to select the most appropriate/promising neurotechnology-aided interventions and/or their combination for the specific case. Then, these interventions can be administered in the clinic and/or at home in sequence, moving from one to another only when patient’s motor recovery plateaus. In this way, comparisons of the efficacy of each intervention (grey arrows) are still possible, and if the selected interventions and/or their combination are suitable, motor recovery could increase.

Conceptualization of longitudinal personalized rehabilitation-treatment designs for patients with severe chronic stroke. Ideally, each patient with severe chronic stroke with a stable motor recovery could be stratified based on objective biomarkers of stroke recovery in order to select the most appropriate/promising neurotechnology-aided interventions and/or their combination for the specific case. Then, these interventions can be administered in the clinic and/or at home in sequence, moving from one to another only when patient’s motor recovery plateaus. In this way, comparisons of the efficacy of each intervention (grey arrows) are still possible, and if the selected interventions and/or their combination are suitable, motor recovery could increase.

, , , , , , , , , , , ,

Leave a comment

[ARTICLE] Potential of Stem Cell-Based Therapy for Ischemic Stroke – Full Text

Ischemic stroke is one of the major health problems worldwide. The only FDA approved anti-thrombotic drug for acute ischemic stroke is the tissue plasminogen activator. Several studies have been devoted to assessing the therapeutic potential of different types of stem cells such as neural stem cells (NSCs), mesenchymal stem cells, embryonic stem cells, and human induced pluripotent stem cell-derived NSCs as treatments for ischemic stroke. The results of these studies are intriguing but many of them have presented conflicting results. Additionally, the mechanism(s) by which engrafted stem/progenitor cells exert their actions are to a large extent unknown. In this review, we will provide a synopsis of different preclinical and clinical studies related to the use of stem cell-based stroke therapy, and explore possible beneficial/detrimental outcomes associated with the use of different types of stem cells. Due to limited/short time window implemented in most of the recorded clinical trials about the use of stem cells as potential therapeutic intervention for stroke, further clinical trials evaluating the efficacy of the intervention in a longer time window after cellular engraftments are still needed.


The number of stroke-related deaths is increasing and stroke remains one of the major causes of deaths and disability worldwide (12). Between 1990 and 2010, the global incidence rate of stroke seemed to be stable, while other parameters such as the incidence of first stroke, prevalence of stroke, disability-adjusted life-years lost due to stroke, and the number of stroke-related deaths increased by 68, 84, 12, and 26%, respectively (1). Differences between rates and numbers might reflect variations in population structure, increase in life expectancy, and the global improvement of health care services.

Two main types of stroke are recognized: ischemic and hemorrhagic stroke. Ischemic stroke accounts for over 80% of the total number of strokes. Thrombolysis and/or thrombectomy is the only validated therapeutic strategy for ischemic stroke (34). Neurorestorative stem cell-based therapy is currently a major priority for stroke research (56). Following ischemic events an inflammatory cascade, is initiated eventually leading to damage of brain tissue.

Different Cellular Sources Used for Stem Cell-Based Therapy of Stroke

The drastic damage to brain tissues following ischemic stroke includes not only destruction of a heterogeneous population of brain cell types, but also major disruption of neuronal connections and vascular systems. Several types of stem/progenitor cells such as embryonic stem cells (ESCs), neural stem/precursor cells, mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and induced neurons have been assessed as potential cellular-based therapy for stroke. The results of studies of these different cellular types are conflicting. In some studies, the engrafted cells survived, proliferated, differentiated, and restored lost neuronal and vascular elements. Other studies have shown only a limited neurorestorative ability on the part of transplanted cells. In the next section of this review, we elaborate on different stem cell types used for cellular-based therapy of stroke (Figure 1).


Figure 1. Stem cells and neural progenitor cells have been used to replace neural tissue death following a cerebral insult. Adult (mesenchymal and neural stem cells) and embryonic stem cells (ESCs) exhibited excellent differentiation capacity toward the neural phenotypes (neurons, oligodendrocytes, and astrocytes) in vitro and in vivo. In our view instead, induced pluripotent stem cells (iPSCs) constitute the greatest prospect for a future cell therapy. iPSCs are derived directly from the patient’s connective tissue through a small biopsy and exhibit the same properties of ESCs, overcoming the problems related to immune rejection, and bypassing the need for embryos. They can be generated in a patient-matched manner, implicating that each individual could have their own pluripotent stem cell line. Finally, iPSCs can be used in personalized drug discovery and to understand and deepen the patient-specific basis of disease (710).


Continue —> Frontiers | Potential of Stem Cell-Based Therapy for Ischemic Stroke | Neurology

, , , ,

Leave a comment

[ARTICLE] The Alteration Visual Field Defect in Ischemic Stroke Patients After Three Months Therapy – Full Text PDF


Background: Ischemic stroke are lack of blood flow to the brain and it could influence the visual field. Approximately more than half of the ischemic stroke patient have visual defect.

Objective : Disturbance of blood flow on visual pathway have impact to the visual field defect.  In stroke ischemic patient, recirculation of penumbra at the brain on the third months after onset can  rehabilitate the visual pathway, also it will improve the outcome of visual filed defect. So it could be initial detection for rehabiltation of visual field defect.

Methods: This study was intended to compere visual field defect of ischemic stroke patient after three months therapy conducted form September 2014 – February 2015 in Mohammad Hoesin General Hospital Palembang. A total of 12 patients who met the inclusion criteria were recruited by consecutive sampling. All patients were endure based on ophthalmology and visual field examination using Humphrey Field Analyzer twice. First after relieving from the attack of stroke and second after three months therapy. Measurement of standard have to compare the value of MD, VFI, PSD, PD and pattern visual field defect.

Results: There were significant difference in value of MD, VFI, PSD  and PD<0,5% for both eyes on stroke ischemic patients after three months therapy. Almost all variable value were increasing to improvement of defect. The most common type of visual field defect  is homonymous hemianopia.

Conclusion: There were improvement in visual field defect in patients with stroke ischemic after three months therapy.

Full Text: PDF

Source: The Alteration Visual Field Defect in Ischemic Stroke Patients After Three Months Therapy | Lestari | Ophthalmologica Indonesiana

, , , , , , , ,

Leave a comment

[ARTICLE] Prediction of Upper Limb Motor Recovery after Subacute Ischemic Stroke Using Diffusion Tensor Imaging: A Systematic Review and Meta-Analysis – Full Text


Early evaluation of the pyramidal tract using Diffusion Tensor Imaging (DTI) is a prerequisite to decide the optimal treatment or to assess appropriate rehabilitation. The early predictive value of DTI for assessing motor and functional recovery in ischemic stroke (IS) has yielded contradictory results. The purpose is to systematically review and summarize the current available literature on the value of Fractional Anisotropy (FA) parameter of the DTI in predicting upper limb motor recovery after sub-acute IS. MEDLINE, PubMed, EMBASE, Google Scholar and Cochrane CENTRAL searches were conducted from January 1, 1950, to July 31, 2015, which was supplemented with relevant articles identified in the references. Correlation between FA and upper limb motor recovery measure was done. Heterogeneity was examined using Higgins I-squared, Tau-squared. Summary of correlation coefficient was determined using Random Effects model. Out of 166 citations, only eleven studies met the criteria for inclusion in the systematic review and six studies were included in the meta-analysis. A random effects model revealed that DTI parameter FA is a significant predictor for upper limb motor recovery after sub-acute IS [Correlation Coefficient=0.82; 95% Confidence Interval-0.66 to 0.90, P value<0.001]. Moderate heterogeneity was observed (Tau-squared=0.12, I-squared=62.14). The studies reported so far on correlation between DTI and upper limb motor recovery are few with small sample sizes. This meta-analysis suggests strong correlation between DTI parameter FA and upper limb motor recovery. Well-designed prospective trials embedded with larger sample size are required to establish these findings.


Stroke is a major leading cause of death and disability worldwide especially in the elderly population [1]. Upper limb motor weakness is one of the most frequent complications after stroke with over 50% of stroke patients experiencing residual motor deficit [2]. Despite advances in treatment of acute ischemic stroke (IS) and post-stroke rehabilitation, the dependency rate after stroke still reaches 20%-30% [3]. Prognostication of upper limb motor outcomes after stroke is an important for specific rehabilitation strategies and final motor outcomes but, considered a difficult task. Many studies have tried to predict motor outcome in hemiparetic stroke patients using clinical findings [4,5], electrophysiological methods [6,7], and functional neuroimaging [8,9]. However, these studies have an inherent weakness that they were unable to visualize the corticospinal tract (CST), the most important structure for motor control, especially for fine motor control of the hand in humans [10].
Diffusion tensor imaging (DTI) is an advance non-invasive magnetic resonance imaging technique used to characterize the orientation properties of diffusion process of water molecules. DTI has a unique advantage in visualization and estimation of CST which is the most important neural tract for mainly upper limb motor function [11]. DTI permits the imaging of axonal pathways of the living brain and provides information about tissue microstructure by measuring fractional anisotropy (FA) [12]. FA is an index of the diffusion characteristics of water molecules preferentially directed along the axis of major axonal pathways. FA of the entire tract, acquired early after stroke, reflect acute and permanent damage to pyramidal tracts to determine clinical motor deficit and outcome. A tissue is considered to be fully isotropic when its FA is equal to 0, and fully anisotropic when its FA is equal to 1 [13].
Over the past two decades, numerous cross-sectional DTI studies have examined the relationships between age and the degree of anisotropy FA in white matter tracts [14]. Cross-sectional studies have demonstrated that older adults display lower FA values and higher mean diffusivity and radial diffusivity values compared with younger adults [15,16], with age correlations relatively weak during adulthood and stronger in senescence [17,18]. Currently, the most widely used invariant measure of anisotropy is FA described originally by Basser and Pierpaoli [12]. In the parametric data obtained from DTI, taking advantage of the much larger FA values of highly directional white matter structures, FA images are used to distinguish white matter and non-white matter tissues [19]. Studies that have examined small homogeneous samples of subcortical stroke patients have found that large asymmetries in FA are associated with poorer motor recovery [20,21]. Findings from recent studies have demonstrated the predictive value of DTI for motor outcome after stroke [22,23], however, it is not yet used routinely to make a prognosis but there have been some interesting recent developments in this area. Therefore, the purpose of this review is to establish the predictive value of DTI for upper limb motor recovery in IS patients.

Continue —> Prediction of Upper Limb Motor Recovery after Subacute Ischemic Stroke Using Diffusion Tensor Imaging: A Systematic Review and Meta-Analysis

, , , , , , , , , ,

Leave a comment

[Abstract] Mobile game-based virtual reality rehabilitation program for upper limb dysfunction after ischemic stroke.

Source: Mobile game-based virtual reality rehabilitation program for upper limb dysfunction after ischemic stroke – IOS Press

, , , , , , , , , , ,

Leave a comment

[Abstract] Effect of Electroacupuncture Intervention on Rehabilitation of Upper Limb Motor Function in Patients with Ischemic Stroke. – PubMed – NCBI



To observe the effect of electro-elongated needle intervention on rehabilitation of upper limb motor function in patients with ischemic stroke.


A total of 100 ischemic stroke patients were equally and randomly divided into manual acupuncture group and electro-elongated needle group (n=50 cases/group). For patients of the manual acupuncture group, filiform needles were respectively inserted into Jianyu (LI 15), Jiquan (HT 1), Shousanli (LI 10), Neiguan (PC 6) and Hegu (LI 4) on the affected side, manipulated with lifting-thrusting reinforcing or reducing method for 40 min, once daily for two weeks except the weekends, and for those of the electro-elongated needle group, elongated needles were repeatedly penetrated from LI 15 to Binao (LI 14), and from LI 10 to Waiguan (TE 5) on the affected side, followed by electrical stimulation for 40 min, once daily for two weeks except weekends. The therapeutic effect of manual acupuncture and electro-elongated needle for upper extremity rehabilitation was assessed according to the modified upper-extremity Fugl-Meyer Assessment (FMA) and Wolf Motor Function Test (WMFT) separately. The surface electromyogram (sEMG) of the deltoid muscle was recorded by using a Megawin Surface Electrogram System and the root mean square (RMS) of the amplitude of sEMG was used to evaluate the functional state of the deltoid muscle.


After the treatment, the score of FMA and WMFT in both manual acupuncture and electro-elongated needle groups were significantly increased compared with pre-treatment in the same one group (P<0.01), suggesting an improvement of the motor function of the upper limbs, but RMS ratios of the amplitude of sEMG were evidently decreased in both groups (P<0.05, P<0.01), suggesting a relief of the abnormal muscular tension. The therapeutic effects of the electro-elongated needle were obviously superior to those of manual acupuncture in up-regulating FMA and WMFT scores and down-regulating RMS ratio (P<0.01).


Electro-elongated needle therapy can effectively improve the motor function of upper limb in ischemic stroke patients and has a better effect in comparison with simple manual acupuncture.

Source: [Effect of Electroacupuncture Intervention on Rehabilitation of Upper Limb Motor Function in Patients with Ischemic Stroke]. – PubMed – NCBI

, , , , , ,

Leave a comment

[Abstract] Promoting recovery from ischemic stroke – Expert Review of Neurotherapeutics –

21 DEC 2015


Over recent decades, experimental and clinical stroke studies have identified a number of neurorestorative treatments that stimulate neural plasticity and promote functional recovery. In contrast to the acute stroke treatments thrombolysis and endovascular thrombectomy, neurorestorative treatments are still effective when initiated days after stroke onset, which makes them applicable to virtually all stroke patients. In this article, selected physical, pharmacological and cell-based neurorestorative therapies are discussed, with special emphasis on interventions that have already been transferred from the laboratory to the clinical setting. We explain molecular and structural processes that promote neural plasticity, discuss potential limitations of neurorestorative treatments, and offer a speculative viewpoint on how neurorestorative treatments will evolve.

Related articles

View all related articles

Source: Promoting recovery from ischemic stroke – Expert Review of Neurotherapeutics –

, , , ,

Leave a comment

[ARTICLE] Influence of Kinesitherapy on Gait in Patients with Ischemic Stroke in the Chronic Period – Full Text PDF


AIM: The study aims to trace the influence of specialized kinesitherapeutic methodology (SKTM) on gait in patients with ischemic stroke in the chronic period (ISChP).

MATERIAL AND METHODS: The study was conducted with 56 patients with ISChP (duration of the disease up to 1 year). For determining changes in gait before and after the treatment a cadence of gait and maximum movement speed were taken into consideration. To determine the cadence, steps are counted for covering 6 meters and 10 meters respectively. The maximum speed of the gait is determined in m / min by dividing undergone distance (m) and time (min).

RESULTS: Patients were found to significantly normalize the parameters of gait. Compared to the initial data, there is a significant reduction in the number of steps on 6 and 10 meters and a tendency to increase the speed of gait, with the significant change during the 1st month with a level of significance of p <0.001.

CONCLUSION: The applied specialized kinesitherapeutic methodology continued later as exercise program at home, which significantly improved gait cadence and speed of movement in patients with ischemic stroke in the chronic period and is with a supportive prolonged exposure.

Full Text PDF


, , , , ,

Leave a comment

[ARTICLE] Non-invasive electric current stimulation for restoration of vision after unilateral occipital stroke


Occipital stroke often leads to visual field loss, for which no effective treatment exists. Little is known about the potential of non-invasive electric current stimulation to ameliorate visual functions in patients suffering from unilateral occipital stroke. One reason is the traditional thinking that visual field loss after brain lesions is permanent. Since evidence is available documenting vision restoration by means of vision training or non-invasive electric current stimulation future studies should also consider investigating recovery processes after visual cortical strokes. Here, protocols of repetitive transorbital alternating current stimulation (rtACS) and transcranial direct current stimulation (tDCS) are presented and the European consortium for restoration of vision (REVIS) is introduced. Within the consortium different stimulation approaches will be applied to patients with unilateral occipital strokes resulting in homonymous hemianopic visual field defects. One goal is to evaluate effects of the stimulation on vision parameters, vision-related quality of life, and physiological parameters that allow conclude about the mechanisms of vision restoration as induced by electrical current stimulation. These include EEG-spectra and coherence measures, and visual evoked potentials. The design of stimulation protocols involves an appropriate sham-stimulation condition and sufficient follow-up periods to test whether the effects are stable.

This is the first application of non-invasive current stimulation for vision rehabilitation in stroke-related visual field deficits. Positive results of the trials could have far-reaching implications for clinical practice. The ability of non-invasive electrical current brain stimulation to modulate the activity of neuronal networks may have implications for stroke rehabilitation also in the visual domain.


via Non-invasive electric current stimulation for restoration of vision after unilateral occipital stroke.

, , , , , , , , ,

Leave a comment

%d bloggers like this: